Crossover investors join Moderna's $450M round

Moderna Therapeutics Inc. (Cambridge, Mass.) raised $450 million in the largest biotech venture financing on record.

Moderna CFO Lorence Kim told BioCentury the round was not a "typical crossover round" that would precede an IPO by three to six months, and that the company does not yet have concrete plans to go public. The company said it has $800 million in cash. ...